Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cytodyn Inc (OP: CYDY )

4.470 USD +0.190 (+4.44%)
Streaming Delayed Price Updated: 8:19 AM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,300
Open 4.280
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 4.280
Today's Range 4.280 - 4.470
52wk Range 0.8100 - 10.01
Shares Outstanding 212,082,779
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Proactive news headlines including GR Silver Mining, XPhyto Therapeutics, Empress Royalty and Nano One Materials
Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: 
From GlobeNewswire News Releases
Proactive news headlines including Algernon Pharmaceuticals, Benchmark Metals, Imagine AR Inc and Q BioMed Inc
Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies: 
From GlobeNewswire News Releases

Performance

YTD
-25.13%
-25.13%
1 Month
-4.08%
-4.08%
3 Month
+68.05%
+68.05%
6 Month
+41.90%
+41.90%
1 Year
+325.71%
+325.71%

More News

Read More
Studies Indicating T-Cells May Be Needed For Long-Term Protection From The SARS-Cov-2 Virus
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Studies Indicating T-Cells May Be Needed For Long-Term Protection From The SARS-Cov-2 Virus
From PR Newswire
FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19
From PR Newswire
FDA Resumes eIND Approval for Severe-to-Critical COVID-19 Patients Use of Vyrologix™ (leronlimab) Following Full Enrollment in CytoDyn’s Phase 3 Trial
From GlobeNewswire News Releases
CytoDyn Completes Enrollment for Phase 3 Registrational Trial for 390 Patients with Severe-to-Critical COVID-19
From GlobeNewswire News Releases
CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments
From GlobeNewswire News Releases
New Pharma Trials Making Big Gains in Fight Against Triple-Negative Breast Cancer (TNBC)
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
New Pharma Trials Making Big Gains in Fight Against Triple-Negative Breast Cancer (TNBC)
From PR Newswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.